Shallow whole genome re-sequencing to precisely predict benefit from PARP inhibitor.
| Autor: | Sandoval JL; Department of Oncology, Hopitaux Universitaires de Geneve, Geneva, Switzerland., Labidi-Galy SI; Department of Oncology, Hopitaux Universitaires de Geneve, Geneva, Switzerland. intidhar.labidi-galy@hcuge.ch.; Department of Medicine, Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland. intidhar.labidi-galy@hcuge.ch. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Oncogene [Oncogene] 2023 Nov; Vol. 42 (48), pp. 3543-3544. Date of Electronic Publication: 2023 Nov 09. |
| DOI: | 10.1038/s41388-023-02871-8 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Full text from SpringerLink